Key result
Lipid mediators block monocyte migratory conversion, impairing cell emigration in progressive atherosclerotic plaques.
Answers are grounded in this paper and cite their sources.
Reveals emigration of monocyte-derived cells from regressive atherosclerotic plaques, indicating that impaired cellular egress promotes plaque progression.
Some monocytes normally take up residence in tissues as sessile macrophages, but others differentiate into migratory cells resembling dendritic cells that emigrate to lymph nodes. In an in vitro model of a vessel wall, lipid mediators lysophosphatidic acid and platelet-activating factor, whose signals are implicated in promoting atherosclerosis, blocked conversion of monocytes into migratory cells and favored their retention in the subendothelium. In vivo studies revealed trafficking of monocyte-derived cells from atherosclerotic plaques during lesion regression, but little emigration was detected from progressive plaques. Thus, progression of atherosclerotic plaques may result not only from robust monocyte recruitment into arterial walls but also from reduced emigration of these cells from lesions.
No takes yet. Share an insight, caveat, or question.
Llodrá et al. (2004) studied Atherosclerosis. Lysophosphatidic acid and platelet-activating factor was evaluated on Emigration of monocyte-derived cells. Lipid mediators blocked monocyte conversion into migratory cells, and progressive atherosclerotic plaques showed reduced monocyte-derived cell emigration compared to regressive plaques.
Synapse has enriched 10 related papers. Consider them for comparative context: